| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7d0e306a483444c3f761dafd7114a2e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-142 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-44791 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-10 |
| filingDate |
2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e4c8f5408b729a327c87ab1ab131a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f29eed298eeeb7fda6ff0f0f00553576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073508388d5e2872ab4a629cca66657a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf41d491bcc470cda4e71a0d2adb0969
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8959fdaf8c5f9f6c7b7f76041d83c4d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d2f64e0ad0512c329fb608b79d02fa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_270da43fc60486331d41a91b4efeeee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f804d3067c6efa835fa76b305cabcac6 |
| publicationDate |
2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015154350-A1 |
| titleOfInvention |
Assays, methods and apparatus for assessing rna disruption |
| abstract |
Various embodiments are described herein related to an assay, method and apparatus for performing an RNA Disruption Assay (RDA) for cellular RNA optionally in response to a cytotoxic treatment such as chemotherapy and/or radiation treatment. The method comprises obtaining at least one electropherogram dataset corresponding to a unique biological sample comprising the cellular RNA at a time point, optionally during or after the treatment; determining values for features from at least two shifted regions of the at least one electropherogram dataset, the shifting being due to the treatment; and optionally determining an RDA score based on a combination of the values of the features. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018262557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10731222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015315656-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10855748-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11031096-B2 |
| priorityDate |
2012-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |